Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -46.70% | -56.32% | -95.97% | -2.47% | 87.47% |
| Total Depreciation and Amortization | 530.45% | 453.48% | 615.61% | -14.62% | -15.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 54.39% | -631.55% | 100.61% | 143.48% | -354.82% |
| Change in Net Operating Assets | 113.57% | 228.51% | -112.75% | 1,421.50% | -233.36% |
| Cash from Operations | 73.38% | 267.60% | -66.47% | 111.30% | -47.82% |
| Capital Expenditure | 66.67% | 95.14% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 66.67% | 95.14% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -171.43% | -94.44% | -265.52% | -38.10% | -12.00% |
| Issuance of Common Stock | -69.90% | -92.35% | -92.54% | -27.27% | 63.49% |
| Repurchase of Common Stock | -- | 100.00% | 100.00% | 100.00% | -144.44% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 55.45% | 97.90% | 146,418.52% | 97.93% | -197.06% |
| Foreign Exchange rate Adjustments | 94.15% | -213.27% | 126.53% | -199.52% | -327.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.09% | 467.67% | -769.10% | 106.22% | -53.04% |